STROMBAFORT (Stanozolol) is a dihydrotestosterone (DHT) derived anabolic androgenic steroid, or more specifically a structurally altered form. STROMBAFORT is the DHT hormone with two structural changes that give us the Stanozolol compound. The first alteration is the introduction of an attached pyrazol group at the A-ring of the hormone replacing the 3-keto group. This modification officially classifies Stanozolol as a heterocyclic steroid. The hormone also carries an added methyl group in order to protect hormone after administration. This structural change takes place at the 17th carbon position officially classifying Stanozolol as a C17-alpha alkylated (C17-aa) anabolic steroid.
Dosage & method of use
Standard male STROMBAFORT (Stanozolol) doses will normally fall in the 25-50 mg range;
For performance enhancing athletes, STROMBAFORT doses normally range from 50-100 mg per day. Total use should fall in the 4-6 week range;
Not recommended for female use.
The side effects of Stanozolol most certainly exist, but they largely fall into the category of possible rather than guaranteed;
For men: can include testicular atrophy or the shrinking of the testicles, reduced sperm count;
For women: can include enlargement of the clitoris, changes in the body contour growth of facial hair, disruption of the menstrual cycle, deepened voice and infertility.